Morning blood pressure surge, morning platelet aggregation, and silent cerebral infarction in older Japanese hypertensive patients

Journal of Hypertension

Volumn 29, Issue 12, 2011, Pages 2433-2439

  Kario, Kazuomi ^a   Yano, Yuichiro ^a,b   Matsuo, Takefumi ^c   Hoshide, Satoshi ^a   Asada, Yujiro ^d   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Hemostatic factor; morning blood pressure surge; neurohumoral factor; platelet aggregation; silent cerebral infarction

Indexed keywords

AGED; ANTICOAGULATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN INFARCTION; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MORNING BLOOD PRESSURE SURGE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SILENT CEREBRAL INFARCTION; SMALL SIZED PLATELET AGGREGATION; THROMBOCYTE AGGREGATION;

EID: 81355160210     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834cf1c0     Document Type: Article

References (20)

1. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733-743.
2. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001; 6:63-72.
3. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107:1401-1406.
4. Gkaliagkousi E, Passacquale G, Douma S, Zamboulis C, Ferro A. Platelet activation in essential hypertension: Implications for antiplatelet treatment. Am. J. Hypertens 2010; 23:229-236.
5. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J. Am. Coll Cardiol 2004; 44:415-422.
6. Lip GY, Blann AD. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 2000; 101:218-220.
7. Kario K, Yano Y, Matsuo T, Hoshide S, Eguchi K, Shimada K. Additional impact of morning hemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. Eur Heart J. 2011; 32:574-580.
8. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin Invest 1991; 87:1234-1240.
9. Goto S, Sakai H, Goto M, Ono M, Ikeda Y, Handa S, Ruggeri ZM. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999; 99:608-613.
10. Kawano K, Yoshino H, Aoki N, Udagawa H, Watanuki A, Hioki Y, et al. Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clin Cardiol 2002; 25:154-160.
11. Kario K, Matsuo T, Kobayashi H, Hoshide S, Shimada K. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J. Am. Coll Cardiol 2001; 37:871-877.
12. Ozaki T, Satoh K, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218:284-294.
13. Matsuo T, Matsuo M, Kario K, Suzuki S. Characteristics of heparin-induced platelet aggregates in chronic hemodialysis with long-term heparin use. Haemostasis 2000; 30:249-257.
14. Blann AD, McCollum CN. von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis 1999; 10:375-380.
15. Touyz RM, Schiffrin EL. Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2 concentrations inessential hypertension. Hypertension 1993; 22:853-862.
16. Blann AD, Nadar S, Lip GY. Pharmacological modulation of platelet function in hypertension. Hypertension 2003; 42:1-7.
17. Torsellini A, Becucci A, Citi S, Cozzolino F, Guidi G, Lombardi V, et al. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation. Haematologica 1982; 67:860-866.
18. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J. Thromb Haemost 2006; 4:1186-1193.
19. Padró T, Steins M, Li CX, Mesters RM, Hammel D, Scheld HH, Kienast J. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc Res 1997; 36:28-36.
20. Wizner B, Dechering DG, Thijs L, Atkins N, Fagard R, O Brien E, et al. Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension. J. Hypertens 2008; 26:1328-1335